Hikma Pharmaceuticals Public annual operating margin
2020
2021
2022
2023
2024
2025
Hikma Pharmaceuticals Public Operating Margin Growth & History (HIK)
Hikma Pharmaceuticals Public's operating margin was 16.18% for fiscal 2025.
View full Hikma Pharmaceuticals Public company overviewHikma Pharmaceuticals Public annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 16.18% | −3.39 pp |
| 2024 | 2024-12-31 | 19.57% | +6.81 pp |
| 2023 | 2023-12-31 | 12.77% | +1.56 pp |
| 2022 | 2022-12-31 | 11.20% | −11.59 pp |
| 2021 | 2021-12-31 | 22.80% | −1.94 pp |
| 2020 | 2020-12-31 | 24.73% | — |
Hikma Pharmaceuticals Public operating margin trends
Over the last five fiscal years, Hikma Pharmaceuticals Public's operating margin decreased from 24.73% to 16.18%, a change of −8.55 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hikma Pharmaceuticals Public source filings ↗Community posts
Hikma’s epinephrine nasal spray advances into regulatory review
Hikma ($HIK) said regulators in the United States, Europe and the UK have accepted submissions for its investigational epinephrine nasal spray for review. The company has also filed in Canada and intends to expand submissions to additional ...